Oxybutynin Chloride Extended Release (OXYBUTYNIN CHLORIDE)
Oxybutynin Chloride Extended Release (OXYBUTYNIN CHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Oxybutynin Chloride Extended Release; Generic name: OXYBUTYNIN CHLORIDE; Manufacturer: American Health Packaging.
| Brand name | Oxybutynin Chloride Extended Release |
|---|---|
| Generic name | OXYBUTYNIN CHLORIDE |
| Manufacturer | American Health Packaging |
| Used for | 1 INDICATIONS AND USAGE Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. (1) Oxybutynin chloride extended-release tablets are also indicat |
| Dosage | 2 DOSAGE AND ADMINISTRATION Oxybutynin chloride extended-release tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed. Oxybutynin chloride extended-release tablets may be administered with or without food. Oxybutynin chloride extended-release tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed. Oxybutynin chloride extended-release tablets may be administered with or without food. (2) Adults: Start wi |
| Active ingredient(s) | OXYBUTYNIN CHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c71bdfb-01db-49ac-a8e9-0037df0d24af |